The current paradigm concerning the kinetics of hematopoiesis is that
only the most primitive pluripotential bone marrow stem cells can supp
ort prolonged hematopoiesis whereas more differentiated, lineage-commi
tted stem cells can only contribute to a particular lineage for a limi
ted period of time. In this study, we present evidence that in mice, t
he spleen contains a long-lived myeloid-committed stem cell population
(s) that continuously replenishes the mature myeloid lineage for at le
ast 9 months. After myeloid-specific retroviral-mediated gene transfer
, the exogenous gene could be detected in thioglycollate-induced macro
phages and granulocytes by Southern blot analysis and by in situ polym
erase chain reaction on an individual cell basis. The targeted stem ce
ll population does not repopulate the bone marrow in secondary recipie
nts and did not give rise to cells other than cells of the myeloid lin
eage, It therefore represents the first nonpluripotential stem cell po
pulation capable of replenishing a hemopoietic lineage for a long peri
od of time. The ability to target a myeloid-specific stem cell could f
acilitate gene therapy of congenital disorders of the myeloid system s
uch as lysosomal storage diseases. It also offers a unique opportunity
to assess the immunologic consequences of expressing an exogenous gen
e of choice exclusively in the myeloid lineage. (C) 1998 by The Americ
an Society of Hematology.